Vertex Pharmaceuticals Statistics

Total Valuation

LON:0QZU has a market cap or net worth of GBP 86.74 billion. The enterprise value is 79.10 billion.

Market Cap	86.74B
Enterprise Value	79.10B

Important Dates

The next estimated earnings date is Monday, February 2, 2026.

Earnings Date	Feb 2, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	253.72M
Shares Outstanding	n/a
Shares Change (YoY)	+0.11%
Shares Change (QoQ)	-0.50%
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	95.09%
Float	252.93M

Valuation Ratios

The trailing PE ratio is 31.72 and the forward PE ratio is 22.33.

PE Ratio	31.72
Forward PE	22.33
PS Ratio	9.95
PB Ratio	6.73
P/TBV Ratio	7.38
P/FCF Ratio	34.94
P/OCF Ratio	31.36
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 21.51, with an EV/FCF ratio of 31.86.

EV / Earnings	28.93
EV / Sales	8.99
EV / EBITDA	21.51
EV / EBIT	23.23
EV / FCF	31.86

Financial Position

The company has a current ratio of 2.36, with a Debt / Equity ratio of 0.11.

Current Ratio	2.36
Quick Ratio	1.84
Debt / Equity	0.11
Debt / EBITDA	0.37
Debt / FCF	0.55
Interest Coverage	354.41

Financial Efficiency

Return on equity (ROE) is 22.31% and return on invested capital (ROIC) is 15.51%.

Return on Equity (ROE)	22.31%
Return on Assets (ROA)	12.04%
Return on Invested Capital (ROIC)	15.51%
Return on Capital Employed (ROCE)	22.25%
Revenue Per Employee	1.43M
Profits Per Employee	448,206
Employee Count	6,100
Asset Turnover	0.50
Inventory Turnover	4.10

Taxes

In the past 12 months, LON:0QZU has paid 575.51 million in taxes.

Income Tax	575.51M
Effective Tax Rate	17.39%

Stock Price Statistics

The stock price has decreased by -1.02% in the last 52 weeks. The beta is 0.32, so LON:0QZU's price volatility has been lower than the market average.

Beta (5Y)	0.32
52-Week Price Change	-1.02%
50-Day Moving Average	421.55
200-Day Moving Average	443.22
Relative Strength Index (RSI)	65.82
Average Volume (20 Days)	625

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.67

Income Statement

In the last 12 months, LON:0QZU had revenue of GBP 8.72 billion and earned 2.73 billion in profits. Earnings per share was 10.58.

Revenue	8.72B
Gross Profit	4.60B
Operating Income	3.37B
Pretax Income	3.31B
Net Income	2.73B
EBITDA	3.51B
EBIT	3.37B
Earnings Per Share (EPS)	10.58

Full Income Statement

Balance Sheet

The company has 4.68 billion in cash and 1.36 billion in debt, giving a net cash position of 7.57 billion.

Cash & Cash Equivalents	4.68B
Total Debt	1.36B
Net Cash	7.57B
Net Cash Per Share	n/a
Equity (Book Value)	12.88B
Book Value Per Share	50.73
Working Capital	4.53B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.77 billion and capital expenditures -283.29 million, giving a free cash flow of 2.48 billion.

Operating Cash Flow	2.77B
Capital Expenditures	-283.29M
Free Cash Flow	2.48B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 52.72%, with operating and profit margins of 38.70% and 31.35%.

Gross Margin	52.72%
Operating Margin	38.70%
Pretax Margin	37.95%
Profit Margin	31.35%
EBITDA Margin	40.19%
EBIT Margin	38.70%
FCF Margin	28.47%

Dividends & Yields

LON:0QZU does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.11%
Shareholder Yield	-0.11%
Earnings Yield	3.15%
FCF Yield	2.86%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LON:0QZU has an Altman Z-Score of 11.3 and a Piotroski F-Score of 5.

Altman Z-Score	11.3
Piotroski F-Score	5